Thrombus detection device and method

Information

  • Patent Grant
  • 11642508
  • Patent Number
    11,642,508
  • Date Filed
    Tuesday, July 30, 2019
    4 years ago
  • Date Issued
    Tuesday, May 9, 2023
    a year ago
Abstract
A method for thrombus detection comprising employing an elongate tube having at least one opening at a distal end of the elongate tube. A coupling is attached or formed at the proximal end of the elongate tube. The detection of the presence of a thrombus is performed by using a syringe to withdraw blood through the at least one thrombus detection opening at the distal end of the elongate tube. If little or no blood is withdrawn, or if the withdrawal of blood is more difficult than expected, the presence of a thrombus obstructing the openings is indicated.
Description
FIELD OF THE INVENTION

The present invention pertains generally to the field of devices for use in the treatment of venous thrombosis. More particularly, the present invention relates to an apparatus for detecting a thrombus captured in a vena cava filter within a patient's blood vessel.


BACKGROUND

A deep vein thrombosis (DVT) is a blood clot, or thrombus, that forms in a vein. A principal risk of a DVT is that it will embolize and become a life-threatening pulmonary embolism (PE). The disease process venous thromboembolism (abbreviated as VTE or DVT/PE) can refer to DVT and/or PE. The accepted standard of care for patients with DVT is anticoagulant therapy. Inferior vena cava (IVC) filters are typically reserved for those patients who fail anticoagulant therapy, or have a complication or contraindication to anticoagulant therapy. In some cases, both anticoagulant therapy and an IVC filter may be used to treat patients with DVT.


An IVC filter is deployed in the vena cava to capture thrombotic or embolic material before it can cause a PE. The filter may be deployed permanently, or as a temporary IVC filter that may be retrieved after a period of time. A temporary IVC filter may be deployed while thrombolytic medication is administered to reduce the thrombus. The temporary IVC filter would capture any parts of the thrombus that might come loose while the thrombolytic medication is administered. After a period of time, the risk of a PE may be lessened and the filter may be retrieved.


The use of an IVC filter, particularly a temporary IVC filter, may require periodic monitoring to detect whether and to what extent thrombotic material is captured by the IVC filter. As the IVC filter captures thrombotic material, the filter may become burdened with so much thrombotic material that it forms an obstacle for blood flow to the heart. An overly burdened temporary IVC filter may also be filled with enough thrombotic material to affect the collapsibility of the filter making the filter more difficult to retrieve, increasing the risk of dislodging the thrombotic material and causing a PE. Prior to retrieval, thrombus captured in an overly-burdened filter may be treated to reduce the size of the thrombotic material. Treatment may be by chemical means, such as by administration of a thrombolytic agent, by mechanical means, such as by employing a structure that mechanically disrupts the thrombotic material, by pressure such as pressurized fluid injection or sonication of the thrombus or by thermal means, such as by laser or other energetic means for disrupting the thrombus. It will be understood that the foregoing means for treating the thrombus captured in the IVC filter are exemplary only and non-limiting. Alternative means for treating or reducing the thrombus captured within the IVC filter as may be currently or hereinafter known in the art are also contemplated by the present invention. Under all circumstances, however, prior to removing a temporary IVC filter, it is highly desirable to detect both the presence of thrombus in the filter and evaluate its size and effect on withdrawing the temporary IVC filter while controlling the risk of pulmonary embolism as a result of thrombotic material being released from the temporary IVC filter during retrieval.


Known methods of detecting the presence of a thrombus in an IVC filter rely on the use of expensive imaging processes and medical imaging equipment. When it is desired to determine if a thrombus is present in an IVC filter deployed in a patient, the patient is typically moved to an imaging facility. The area in which the filter is deployed in the patient's body is imaged. If the imaging is performed using x-rays, the imaging generates cavagrams or angiograms, which are then analyzed to determine if a thrombus is present in the filter. Other such imaging methods include intravascular ultrasound (“IVUS”), venography, and CT scans.


It would be desirable to be able to determine at the patient's bedside whether a thrombus is present in the IVC filter without the need for imaging, or to make preliminary determinations of the presence of a thrombus in the IVC filter prior to imaging to quantify the presence and size of the thrombus.


SUMMARY OF THE INVENTION

In one embodiment, a thrombus detection device comprises an elongate tube comprising a tube lumen extending at a substantially constant inner diameter from a first opening at a proximal end to a distal tube portion. The distal tube portion comprises a distal portion lumen extending at an increasing inner diameter to a second opening wider than the first opening. The second opening is sufficiently wide to permit entry of a thrombus into the distal portion lumen. The device for detecting the thrombus includes a coupling at the proximal end of the elongate tube which is used to couple a pump or other means, such as a syringe, for withdrawing blood or fluid from the elongate tube.


For purposes of illustration only, the present application will refer to a syringe as the pump or other means. It is expressly intended, however, that the embodiments disclosed herein are not intended to be limited a syringe as a particular type of pump or other means to draw blood into the elongate tube. Rather, other types of pumps, such as a squeeze bulb, a piston pump, a rotary pump, a syringe pump, a vacuum pump, for example, are expressly included within the scope of the embodiments disclosed herein. When coupled to the elongate tube, the pump or syringe is used to draw blood into the distal portion lumen and through the tube lumen of the elongate tube. The presence of a thrombus is indicated by the volume of blood drawn by the pump, i.e., when less blood can be drawn than expected due to obstruction of the tube lumen by the thrombus in the distal portion lumen.


In another embodiment, the elongate tube may be deployed by inserting the tube into a sheath that guides the elongate tube to the site of interest.


In another embodiment, the elongate tube may be deployed by inserting the tube into a lumen of a single or multi-lumen catheter. The catheter may be of the type that includes an attached IVC filter and a port for the lumen that opens proximal to the IVC filter.


The elongate tube in embodiments disclosed herein may be a tube member with a flexible end member attached at the distal end of the tube member. The flexible end member may have a first opening configured to attach to the distal end of the single tubular member and a second opening wider than the first opening. In another embodiment, the elongate tube may be a single component made of a flexible material and having a first opening at the proximal end and a second opening wider than the first opening at the distal end.


In another embodiment, a device is provided for detecting a thrombus, the device comprising an elongate tube with at least one tube lumen extending at a substantially constant inner diameter from a first opening at a proximal end to a distal tube portion. The distal tube portion includes a plurality of openings in fluid communication with at least one of the tube lumens. A coupling is formed or attached at the proximal end of the elongate tube. The coupling is configured to removably couple a syringe or pump, as previously described above, to the first opening of the elongate tube. The syringe is used to draw blood into the at least one thrombus detection opening and through the tube lumen of the elongate tube. The detection of a thrombus is made by using the syringe to draw blood through the elongate tube. The presence of a thrombus is indicated when less blood can be drawn than expected due to obstruction of at least some of the plurality of openings.


Various advantages, aspects and novel features of the present invention, as well as details of an illustrated embodiment thereof, will be more fully understood from the following description and drawings. Other systems, methods and features of the invention will be or will become apparent to one with skill in the art upon examination of the following figures and detailed description. It is intended that all such additional systems, methods, features and advantages be included within this description, be within the scope of the invention, and be protected by the accompanying claims.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of an example of a thrombus detection device used with a catheter having an IVC filter.



FIG. 2A is a perspective view of an example of an elongate tube for detecting a thrombus.



FIG. 2B is a detail view of the example of an elongate tube for detecting a thrombus shown in FIG. 2A at Detail A.



FIG. 2C is a side view of the example of an elongate tube for detecting a thrombus shown in FIG. 2A.



FIG. 2D is a detail view of the example of an elongate tube for detecting a thrombus shown in FIG. 2A at Detail D.



FIG. 3A is a perspective view of another example of a thrombus detection device.



FIG. 3B is another view of the example of a thrombus detection device of FIG. 3A.



FIG. 4A is a perspective view of another example of a thrombus detection device.



FIG. 4B is a detail view of the example of a thrombus detection device of FIG. 4A at Detail C.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Embodiments of the invention will now be described with reference to the Figures, wherein like numerals reflect like elements throughout. The terminology used in the description presented herein is not intended to be interpreted in any limited or restrictive way, simply because it is being utilized in conjunction with detailed description of certain specific embodiments of the invention. Furthermore, embodiments of the invention may include several novel features, no single one of which is solely responsible for its desirable attributes or which is essential to practicing the invention described herein. The words proximal and distal are applied herein to denote specific ends of components of the instrument described herein. A proximal end refers to the end of an instrument nearer to an operator of the instrument when the instrument is being used. A distal end refers to the end of a component further from the operator and extending towards the surgical area of a patient and/or the implant.


The use of the terms “a” and “an” and “the” and similar referents in the context of describing the invention are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. It will be further understood that the terms “comprises,” “comprising,” “includes,” and/or “including,” when used herein, specify the presence of stated features, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and/or groups thereof.


Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. The word “about,” when accompanying a numerical value, is to be construed as indicating a deviation of up to and inclusive of 10% from the stated numerical value. The use of any and all examples, or exemplary language (“e.g.” or “such as”) provided herein, is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.


References to “one embodiment,” “an embodiment,” “example embodiment,” “various embodiments,” etc., may indicate that the embodiment(s) of the invention so described may include a particular feature, structure, or characteristic, but not every embodiment necessarily includes the particular feature, structure, or characteristic. Further, repeated use of the phrase “in one embodiment,” or “in an exemplary embodiment,” do not necessarily refer to the same embodiment, although they may.


As used herein, the term “syringe” shall refer to any device that may be used for withdrawing blood into a tube. For example, a syringe being a simple pump, any suitably configured pump may be used to aspirate blood into a tube. Such types of withdrawing devices include a wide variety of pumps, such as a squeeze bulb, a piston pump, a rotary pump, a syringe pump, a peristaltic pump or a vacuum pump.


Described below with reference to FIGS. 1-4B are examples of devices for detecting a thrombus in a patient's blood vessel. The examples of the devices for detecting a thrombus described below find particularly advantageous use in patients using an inferior vena cava filter (“IVC filter”). After the IVC filter has been deployed, the filter may become burdened with thrombi. In some instances, it may be advantageous or even necessary to break up the thrombotic material captured by the filter. It may be advantageous to determine if the filter has become burdened with thrombotic material at any time during the deployment of the filter. Typically, whether or not the filter has become burdened with thrombotic material is of most interest when the filter is to be removed. Using example implementations of devices for detecting a thrombus, the thrombotic material may be detected to determine the best way to manage the thrombotic material. The devices for detecting at thrombus advantageously permit thrombus detection at a patient's bedside without the need for expensive imaging equipment.


With reference to FIG. 1, according to one embodiment, a central venous access filter (“CVAF”) 100 is composed generally of a single lumen central venous access catheter body 104 having a distal port 108 associated with a catheter lumen 116, an IVC filter 106 attached to a distal end 105 of the catheter body 104. The catheter body 100 includes a hub 118 at the proximal end 103 to provide fluid coupling with the catheter lumen 116.


The IVC filter 106 may be any suitable filtering device configured to capture embolic material of a size that is sufficient to create a risk of a pulmonary embolism if it is not filtered. In an example implementation, the IVC filter 106 may be a self-expanding structure made of a plurality of struts formed to capture a thrombus. A first plurality of struts may attach to the catheter body 102 and a second plurality of struts interconnect to provide a filtering structure.


A thrombus detection device 101 is disposed within the catheter lumen 116 of the catheter body 104 extending from the proximal end 103 to the distal end 105 of the catheter body 104. The thrombus detection device 101 is formed as an elongate tube 102 having a tube lumen 107 extending at a substantially constant inner diameter from a first opening (not shown) at a proximal end 103 to a distal tube portion 111. The distal tube portion 111 includes a resilient section 113 formed of a resilient material. The resilient section 113 of the distal tube portion 111 may have an increasing inner diameter as it extends distally from the distal portion lumen 109 to a second opening 110 that is greater than a diameter of the catheter lumen 116 at the distal end 105 of the catheter body 102. In this configuration, the resilient section 113 has a generally conical shape that opens distally relative to the longitudinal axis of the thrombus detection device 101. The second opening 110 is configured to be sufficiently wide to permit thrombus 120 captured by the IVC filter 106 to abut the resilient portion 111 and at least partially obstruct the second opening 110. It will be understood by those skilled in the art that alternative configurations of the resilient section 113 are contemplated by the embodiments disclosed herein, with the proviso that the resilient section 113 should be capable of being brought into contact with the thrombus 120 without substantial risk of lysing or otherwise disrupting the thrombus 120 and that it have a geometric configuration sufficient to engage the thrombus 120 in a manner that obstructs the second opening 110 and makes withdrawing blood through the elongate tube 102 more difficult than when the second opening 110 is not so obstructed.


The thrombus detection device 101 includes a coupling 112 at the proximal end 103 of the elongate tube 102. The coupling 112 is configured to removably couple a syringe 114 to the first opening of the elongate tube 102 where the syringe is used to draw blood into the distal portion lumen 109 and through the elongate tube 102. When the syringe 114 is coupled to the elongate tube 102, an attempt to withdraw blood may be initiated as the elongate tube 102 is advanced into the region encompassed by the IVC filter 106 and in proximity to the thrombus 120, if present in the IVC filter 106. Gradation markings (not shown) that may be provided on the elongate tube 102 serve to indicate the position of the distal portion lumen 109 relative to the filter 106. That is, that elongate tube 102 has a known length, the length of the catheter body 104 and IVC filter 106 is known, and therefore the position of the distal tube portion 111 relative to the IVC filter 106 may be known by virtue of the graduation markings. As the elongate tube 102 is advanced within the filter 106, blood is withdrawn by the syringe 114. When the distal portion lumen 109 is in proximity to, adjacent to or abutting thrombus 120, the syringe 114 draws the thrombus 120 into the distal portion lumen 109 of the elongate tube 102 and obstruct blood from entering the tube lumen 107 creating a difficulty or inability to withdraw blood into the elongate tube 102 using the syringe 114. This difficulty or inability to withdraw blood into the elongate tube 102 may then be deemed as an indication that the thrombus 120 is present in the filter 106.


The resilient section 113 of the elongate tube 102 may be of a resilient, flexible or elastic material capable of collapsing to a reduced profile when inserted into the catheter body 104. Once the wider second opening 110 extends out through the distal port 108 of the catheter body 104, the resilient section 113 diametrically expands to an enlarged profile.


The elongate tube 102, including the resilient section 113, may be made of a polymeric, metallic or combination polymeric/metallic biocompatible material. The elongate tube 102 in FIG. 1 may be constructed as a single tube having the enlarged resilient section 113 be integral with the remainder of the elongate tube 102. Alternatively, elongate tube 102 may be constructed of single tubular member and a substantially secondary resilient member connected to the distal end of the tubular member as described below with reference to FIGS. 2A-2D.



FIGS. 2A-2D illustrate different views of an example implementation of an elongate tube 150 of a type that may be used in the example shown in FIG. 1. FIG. 2A is a perspective view of the elongate tube 150. FIG. 2B is a detail view of the elongate tube shown in FIG. 2A at Detail A. FIG. 2C is a side view of the elongate tube shown in FIG. 2A. FIG. 2D is a detail view of the elongate tube shown in FIG. 2C at Detail B.


Referring to FIGS. 2A-2D, the elongate tube 150 includes a tube member 152, which forms the tube lumen 107 described above with reference to FIG. 1, and a flexible end member 154, which is the distal tube portion 111 that forms the distal portion lumen 109 described above with reference to FIG. 1. The flexible end member 154 is attached to the tube member 152 at a distal end of the tube member 152. The flexible end member 154 attaches to the elongate tube 150 at a first end member opening 155 sized to fit the opening of the elongate tube 150. The flexible end member 154 opens distally to a second end member opening 157 wider than the first end member opening 155.


The tube member 152 extends from a coupling 156 at a proximal end to the attachment to the flexible end member 154 at a distal end of the tube member 154. A tube lumen 159 extends from the opening at the proximal end to the opening at the distal end. The tube member 152 and the flexible end member 154 may be made of the same or different materials. The tube member 152 may be made of any suitable biocompatible metallic or polymeric material with sufficient flexibility to allow insertion into the tortuous routes that may be formed by body's blood vessels. The flexible end member 154 may be made of any suitable biocompatible metallic or polymeric material with sufficient flexibility to collapse when inserted through a catheter and to self-expand to its un-collapsed state when the flexible end member 154 extends out of the catheter. The tube member 152 may be of any suitable length, which typically depend on the length of the catheter used to deploy the elongate tube 150.


The coupling 156 may be a luer-lock in fluid communication with the first opening at the proximal end of the elongate tube 150, which is in fluid communication with the elongate tube lumen. However, any suitable mechanism for attaching a syringe, or any other suitable fluid withdrawing device, so as to be in fluid communication with the lumen of the elongate tube may be used.


The flexible end member 154 shown in FIGS. 2A-2D is cone shaped. However, the flexible end member 154 may be any suitable shape such that the second end member opening 157 is wider than the first end member opening 155. The shape of the flexible end member 154 should allow for a thrombus to be funneled or guided in towards the first end member opening 155 when blood is being withdrawn into the tube lumen 159. The size of the first end member opening 155 and the inner diameter of the lumen of the elongate tube 152 should be such that the smallest significantly sized thrombus would obstruct blood from flowing into the tube lumen 159 of the elongate tube 152. In another embodiment, the inner diameter of the tube lumen 159 may also be such that thrombi of a desired may pass through the tube lumen 159 along with blood being withdrawn.


The elongate tube 150 in FIGS. 2A-2D may be deployed as a thrombus detection device by inserting the elongate tube 150 into a catheter device such as the catheter device 100 described above with reference to FIG. 1. In one embodiment, the elongate tube 150 includes a length L, as shown in FIG. 2C. The catheter device 100 shown in FIG. 1 is a single lumen device. However, any single or multi-lumen catheter device may be used as well. For example, multi-lumen catheter devices such as those described in U.S. Pat. No. 8,613,753, which is incorporated herein in its entirety, incorporate multiple lumens, at least one of which may be configured for deployment of examples of the devices for detecting a thrombus described herein. One advantage of using a multi-lumen catheter device is that a lumen may be configured for thrombus detection and at least one other lumen may be used for infusion of thrombolytic agents, which may be dispensed when a thrombus is detected. The thrombus detection lumen may be configured by providing an opening to the thrombus detection lumen at a location of the catheter that would put the wide opening of the elongate tube near any thrombi captured in the filter. A hub on the catheter device may be configured to provide an opening through which the elongate tube may be inserted into the thrombus detection lumen.


In an embodiment in which a single lumen catheter such as the catheter 100 shown in FIG. 1 is used, the single lumen may be used for deployment of the thrombus detection device as described above. When a thrombus is detected, thrombolytic agents may be injected into the lumen of the thrombus detection device. The agents exit through the wide opening of the elongate tube, which is advantageously near the thrombus that is the target of the thrombolytic agents.


In another example implementation, the thrombus detection device may be deployed using a simple sheath that may be inserted into the patient's blood vessel. The distal end of the sheath may be placed near a desired location. The desired location may be proximal to an existing filter that may or may not be attached to a catheter body. The sheath may also be a sheath that already contains a catheter that may or may not include an attached filter device so that the sheath contains both the catheter device and the thrombus detection device.


In alternative embodiments, the thrombus detection device need not incorporate a flexible end member with a wide opening for guiding a thrombus towards the opening to the lumen of the elongate tube. Referring to FIGS. 3A-4B, a thrombus detection device 300 includes a catheter having a tip portion 302, a thrombus detection portion 306 and an elongate tube portion 309 integrated as a single catheter member.


The thrombus detection portion 306 is disposed between the tip portion 302 and the elongate tube portion 309 within a region encompassed by an attached IVC filter 304. The thrombus detection portion 306 includes a plurality of openings 312 extending longitudinally along the thrombus detection portion 306. The plurality of openings 312 pass through a wall surface of the thrombus detection portion 306 of the catheter and are in fluid communication with at least one tube lumen formed in the elongate tube portion 309 and the thrombus detection portion 306 of the catheter. The openings 312 may be equally or unequally spaced along the thrombus detection portion 306 and may be positioned at any position about the circumference of the thrombus detection portion 306 of the catheter. The plurality of openings 312 may also comprise a first plurality of openings 312 on one side of the thrombus detection portion 306 and another plurality of openings on the other side of the thrombus detection portion 306.


The attached IVC filter 304 may be any suitable filtering device configured to capture embolic material of a size that is sufficient to create a risk of a pulmonary embolism if it is not filtered. In an example implementation, the IVC filter 304 may be a self-expanding structure made of a plurality of struts formed to capture a thrombus. A first plurality of struts may attach to the catheter body at the distal end of the elongate tube portion 309, and a second plurality of struts interconnect to provide a filtering structure. The IVC filter 304 may be a collapsible self-expanding filter structure that collapses when the thrombus detection portion 306 of the catheter is inserted into a sheath 310, and self-expands when the thrombus detection portion 306 of the catheter extends beyond the distal end of the sheath 310.


The thrombus detection portion 306 of the catheter body is disposed in a region of the catheter body bounded by the IVC filter 304. The openings 312 are in fluid communication with the tube lumen extending through the elongate tube portion 309 of the catheter. The proximal end of the catheter may include a coupling as described above with reference to the embodiments of FIGS. 1-2D. A syringe coupled to the coupling may be used to withdraw blood through the openings 312 and the tube lumen of the elongate tube portion 309 of the catheter.


The IVC filter 304 may be deployed and left in a patient's blood vessel for a prescribed amount of time. While the IVC filter 304 is operating in the patient's blood vessel, the IVC filter 304 may be checked to determine if it is burdened by a thrombus. Typically, the IVC filter 304 is checked prior to its removal. In order to check for a thrombus in the IVC filter 304, a syringe is coupled to the coupling at the proximal end of the catheter. The syringe is then used in an attempt to draw blood into the openings 312 and the elongate tube portion 309 of the catheter. If the IVC filter 304 does not contain any thrombi, the blood will be easily drawn into the openings 312. If the IVC filter 304 contains a thrombus of sufficient size to obstruct the openings, the blood will be obstructed from entry into the openings 312 when an attempt is made to aspirate the blood into the openings 312. As the size of the thrombus increases, the number of obstructed openings 312 increases creating a greater obstruction of blood into the openings 312 and an increase in difficulty withdrawing blood. The relative increase in the difficulty of withdrawing blood provides an indication of the size of the mass of thrombotic material burdening the IVC filter 304.



FIGS. 4A and 4B show another embodiment of a thrombus detection device 400. FIG. 4A is a perspective view of the thrombus detection device 400. FIG. 4B is a detail view of the thrombus detection device 400 at Detail C in FIG. 4A. The thrombus detection device 400 in FIGS. 4A and 4B includes an elongate tube 402, a hub 404, a first syringe line 406 having a first coupling 410, and a second syringe line 408 having a second coupling 412. The elongate tube 402 includes a distal tube portion 403 comprising a plurality of openings 416. The example elongate tube 402 shown in FIG. 4B includes a first thrombus detection opening 416a close to the tip and a substantially aligned second thrombus detection opening 416b a distance away from the first thrombus detection opening 416a. Additional openings 416 may be provided further proximally along the elongate tube 402. Additional openings 416 may also be provided diametrically opposite the first and second openings 416a and 416b.


The elongate tube 402 may include a first lumen in fluid communication with a first plurality of openings and a second lumen in fluid communication with a second plurality of openings. The first plurality of thrombus openings may be distributed on one side of the distal tube portion 403 and the second plurality of openings on the other side of the distal tube portion 403. The hub 404 provides fluid pathways so that the first lumen is in fluid communication with the first syringe line 406 and the second lumen is in fluid communication with the second syringe line 408. As described above with reference to FIGS. 3A and 3B, the openings 416 may be spaced so as to quantify the size of the clot that may be obstructing the blood withdrawal. By attempting to withdraw blood via lumens in fluid communication with openings on opposite sides of the distal tube portion 403, one can determine whether one side of the IVC filter is more burdened than the other side. The indication of the size of the clots and of the distribution of the thrombotic material in the IVC filter provides information that may be used to determine how best to manage the clots.


Example embodiments of devices for detecting a thrombus are described above with reference to FIGS. 1-4B. The examples described with reference to FIGS. 1-2D use an elongate tube having a single lumen that opens to a distal tube portion with a lumen having an inner diameter that increases to a wide opening. Thrombus detection is achieved when attempting to draw blood. The presence of a thrombus in the distal tube portion lumen obstructs blood from flowing into the elongate tube. The examples described with reference to FIGS. 3A-4B use an elongate tube having either a single lumen or multiple lumens in fluid communication with openings at the distal end of the elongate tube.


A method to detect a thrombus within a blood vessel may be performed using any suitable example of the above described devices for detecting a thrombus. The method comprises the steps of:


a. introducing an elongate tube having at least one opening in a distal end of the elongate tube into the blood vessel.


b. positioning the distal end of the elongate tube at a site of interest;


c. attaching a syringe to a coupling at a proximal end of the elongate tube; and


d. using the syringe to withdraw blood through the elongate tube where a thrombus in the at least one opening of the flexible member obstructs the blood withdrawal indicating the presence of the thrombus.


The site of interest indicated in step a may be the region encompassed by a filter. The distal end of the elongate tube may be brought to the region encompassed by the IVC filter through a lumen of a catheter or a sheath extending in the patient's blood vessels to the region encompassed by the IVC filter. The filter may or may not be attached to a distal end of a catheter. The method may thus include the steps of:


a. inserting a sheath into the blood vessel; and


b. inserting the elongate tube to the blood vessel through the sheath.


Alternatively, the method may include the steps of:


a. inserting a catheter body having a lumen with a distal port on a distal end of the catheter body and a proximal port on a proximal end of the catheter body into the blood vessel; and


b. inserting the elongate tube into the proximal port of the catheter body until the distal end of the elongate tube exits the distal port.


In one embodiment, a device for detecting the presence of a thrombus in a patient's blood vessel is disclosed and comprises: an elongate tube comprising a tube lumen extending at a substantially constant inner diameter from a proximal end opening at a proximal end to a distal tube portion comprising a plurality of openings in fluid communication with the tube lumen; and a coupling attached at the proximal end opening of the elongate tube, the coupling configured to configured to removably couple a syringe to the first opening of the elongate tube where the syringe is used to draw blood through the plurality of openings and through the tube lumen of the elongate tube; wherein detection of a thrombus is determined by drawing blood through the openings and through the elongate tube, and indicating the presence of a thrombus when less blood can be drawn than expected due to obstruction of at least some of the plurality of openings. The coupling is a luer-lock. The elongate tube is made of a polymeric material, a metallic material, or a combination thereof. The plurality of openings extend longitudinally along the distal portion of the elongate tube. The plurality of openings includes a first plurality of openings extending along one side of the elongate tube and a second plurality of openings extending along an opposite side of the elongate tube. The tube lumen of the elongate tube is a first lumen, the tube lumen comprises a second lumen, the proximal end opening is a first proximal end opening in fluid communication with the first lumen, the elongate tube comprises a second proximal end opening in fluid communication with the second lumen; the first plurality of openings is in fluid communication with the first lumen; and the second plurality of openings is in fluid communication with the second lumen. Each of the plurality of openings are spaced at equal distances longitudinally along the distal tube portion of the elongate tube, and where the equal distances provide an indication of clot size when multiple openings may be obstructed as the size of the thrombus increases.


Thus there have been described examples of a thrombus detection device which include, generally, an elongate tube extending from a first opening at a proximal end to an at least one opening at a distal end. A coupling is formed at the first opening to permit attachment of a syringe that may be used to withdraw blood through the elongate tube. These and other aspects of the present invention are provided by way of non-limiting examples, with the claims appended hereto serving to define the scope of the subject matter regarded as the invention.

Claims
  • 1. A method to detect a thrombus within a blood vessel, comprising the steps of: a. introducing an elongate tube into the blood vessel, the elongate tube having at least one opening in a distal end of the elongate tube;b. positioning the distal end of the elongate tube at a site of interest;c. withdrawing blood through the elongate tube; andd. detecting presence of thrombus in the at least one opening of the elongate tube when a flow rate of withdrawing blood slows from an unobstructed flow rate.
  • 2. The method of claim 1, where the step of introducing the elongate tube into the blood vessel comprises: a. inserting a sheath into the blood vessel; andb. inserting the elongate tube to the blood vessel through the sheath.
  • 3. The method of claim 1, where the step of introducing the elongate tube into the blood vessel comprises: a. inserting a catheter body having a lumen with a distal port on a distal end of the catheter body and a proximal port on a proximal end of the catheter body into the blood vessel; andb. inserting the elongate tube into the proximal port of the catheter body until the distal end of the elongate tube exits the distal port.
  • 4. The method of claim 3, wherein the step of inserting the elongate tube further comprises inserting the elongate tube such that the elongate tube is reciprocally moveable within the lumen of the catheter body.
  • 5. The method of claim 3, wherein the elongate tube comprises a tube lumen extending at a substantially constant inner diameter from a first opening at a proximal end to a distal tube portion comprising a distal portion lumen extending at an increasing inner diameter to a second opening wider than the first opening, the second opening being sufficiently wide to permit entry of a thrombus into the distal portion lumen and wherein the step of inserting the elongate tube further comprises the step diametrically collapsing the distal tube portion into the catheter body lumen at the proximal port and diametrically expanding the distal portion into an extended position projecting out of the catheter lumen at the distal port.
  • 6. The method of claim 5, wherein the step of withdrawing blood through the elongate tube further comprises the step of attaching a pump to a proximal end of the elongate tube.
  • 7. The method of claim 6, wherein the step of attaching a pump further comprises the step of attaching a syringe, squeeze bulb, a piston pump, a rotary pump, a syringe pump, a peristaltic pump, or a vacuum pump.
  • 8. The method of claim 1, wherein the elongate tube is a catheter body including an IVC filter coupled to a distal end of the catheter body such that a distal port of the catheter body is positioned within a region of the catheter body bounded by the IVC filter, the method further comprising after the step of inserting the catheter body into the blood vessel, deploying the IVC filter.
  • 9. The method of claim 8, wherein the catheter body further comprises a plurality of openings in fluid communication with a catheter lumen, the plurality of openings disposed within the IVC filter, the method further comprising the steps of withdrawing blood through the plurality of openings.
  • 10. The method of claim 9, further comprising the step of attaching a pump at a proximal end of the catheter body.
  • 11. The method of claim 10, wherein the step of attaching a pump further comprises the step of attaching a syringe, squeeze bulb, a piston pump, a rotary pump, a syringe pump, a peristaltic pump, or a vacuum pump.
  • 12. The method of claim 10, wherein the step of attaching a pump further comprises the step of attaching a syringe, squeeze bulb, a piston pump, a rotary pump, a syringe pump, a peristaltic pump, or a vacuum pump.
  • 13. The method of claim 9, further comprising the step of using a relative increase in difficulty of withdrawing blood from the plurality of openings disposed within the IVC as an indication of a thrombotic burden in the IVC filter.
  • 14. The method of claim 1 wherein the elongate tube comprises a first lumen in fluid communication with a first plurality of openings and a second lumen in fluid communication with a second plurality of openings, the first plurality of openings disposed on one side of a distal tube portion and the second plurality of openings disposed on an opposite side of the distal tube portion, further wherein a hub provides fluid pathways such that the first lumen is in fluid communication with a first syringe line and the second lumen is in fluid communication with a second syringe line, and an IVC filter coupled to the elongate tube, the first plurality of openings and the second plurality of openings disposed with the IVC filter.
  • 15. The method of claim 14 wherein the step of detecting a thrombus further includes detecting a side of the IVC filter that is burdened by withdrawing from blood from both the first plurality of openings and the second plurality of openings.
  • 16. The method of claim 15, further comprising the step of using a relative increase in difficulty of withdrawing blood from the first plurality of openings and the second plurality of openings disposed within the IVC as an indication of a thrombotic burden in the IVC filter.
  • 17. The method of claim 14, further comprising the step of attaching a pump to each of the first syringe line and the second syringe line.
  • 18. The method of claim 1, further comprising the step of attaching a syringe to a coupling at a proximal end of the elongate tube prior to the withdrawing step.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional of and claims the benefit of priority to U.S. patent application Ser. No. 15/136,636 filed Apr. 22, 2016, now U.S. Pat. No. 10,376,685 issued Aug. 13, 2019, which claims the benefit of priority to U.S. Provisional Patent Application Ser. No. 62/151,812 filed Apr. 23, 2015, which is herein incorporated by reference in its entirety. This Application is related to commonly owned and U.S. patent application Ser. No. 14/137,931 filed Dec. 20, 2013, which is a continuation of U.S. patent application Ser. No. 12/684,839, filed Jan. 8, 2010, now U.S. Pat. No. 8,613,753, which, in turn, is a continuation-in-part of U.S. patent application Ser. No. 11/849,225, filed Aug. 31, 2007, now U.S. Pat. No. 8,668,712; the contents of each of the foregoing are incorporated by reference herein.

US Referenced Citations (225)
Number Name Date Kind
3671979 Moulopoulos Jun 1972 A
4901731 Millar Feb 1990 A
4921479 Grayzel May 1990 A
4969891 Gerwertz Nov 1990 A
5046503 Schneiderman Sep 1991 A
5053008 Bajaj Oct 1991 A
5112347 Taheri May 1992 A
5163928 Hobbs et al. Nov 1992 A
5201757 Heyn et al. Apr 1993 A
5549626 Miller et al. Aug 1996 A
5569215 Crocker Oct 1996 A
5624596 McNamara et al. Apr 1997 A
5707389 Louw et al. Jan 1998 A
5713917 Leonhardt et al. Feb 1998 A
5715829 Cori et al. Feb 1998 A
5766151 Valley et al. Jun 1998 A
5769816 Barbut et al. Jun 1998 A
5791341 Bullard Aug 1998 A
5795322 Boudewijn Aug 1998 A
5795325 Valley et al. Aug 1998 A
5797920 Kim Aug 1998 A
5814064 Daniel et al. Sep 1998 A
5833650 Imran Nov 1998 A
5848964 Samuels Dec 1998 A
5879499 Corvi Mar 1999 A
5893868 Hanson et al. Apr 1999 A
5925016 Chornenky et al. Jul 1999 A
5947994 Louw et al. Sep 1999 A
5947995 Samuels Sep 1999 A
5954742 Osypka Sep 1999 A
5976172 Homsma et al. Nov 1999 A
5980478 Gorsuch et al. Nov 1999 A
5980555 Barbut et al. Nov 1999 A
5989281 Barbut et al. Nov 1999 A
6007544 Kim Dec 1999 A
6036654 Quinn et al. Mar 2000 A
6051014 Jang Apr 2000 A
6086605 Barbut et al. Jul 2000 A
6090097 Barbut et al. Jul 2000 A
6117154 Barbut et al. Sep 2000 A
6135991 Muni et al. Oct 2000 A
6136016 Barbut et al. Oct 2000 A
6152909 Bagaoisan et al. Nov 2000 A
6165179 Cathcart et al. Dec 2000 A
6171328 Addis Jan 2001 B1
6178968 Louw et al. Jan 2001 B1
6231544 Tsugita et al. Mar 2001 B1
6224627 Armstrong et al. May 2001 B1
6235045 Barbut et al. May 2001 B1
6251093 Valley et al. Jun 2001 B1
6270477 Bagaoisan et al. Aug 2001 B1
6277138 Levinson et al. Aug 2001 B1
6287321 Jang Sep 2001 B1
6315792 Armstrong et al. Nov 2001 B1
6336934 Gilson et al. Jan 2002 B1
6344049 Levinson et al. Feb 2002 B1
6344053 Boneau Feb 2002 B1
6361545 Macoviak et al. Mar 2002 B1
6379373 Sawhney et al. Apr 2002 B1
6383196 Leslie et al. May 2002 B1
6423086 Barbut et al. Jul 2002 B1
6432122 Gilson et al. Aug 2002 B1
6443971 Boylan et al. Sep 2002 B1
6454741 Muni et al. Sep 2002 B1
6468291 Bates et al. Oct 2002 B2
6482171 Corvi et al. Nov 2002 B1
6511503 Burkett et al. Jan 2003 B1
6537294 Boyle et al. Mar 2003 B1
6537296 Levinson et al. Mar 2003 B2
6537297 Tsugita et al. Mar 2003 B2
6544279 Hopkins et al. Apr 2003 B1
6547788 Maguire et al. Apr 2003 B1
6561996 Gorsuch May 2003 B1
6569148 Bagaoisan et al. May 2003 B2
6585639 Kotmel et al. Jul 2003 B1
6589264 Barbut et al. Jul 2003 B1
6592546 Barbut et al. Jul 2003 B1
6596011 Johnson et al. Jul 2003 B2
6616680 Theilen Sep 2003 B1
6623507 Saleh Sep 2003 B2
6635070 Leeflang et al. Oct 2003 B2
6669708 Nissenbaum et al. Dec 2003 B1
6685722 Rosenbluth et al. Feb 2004 B1
6689148 Sawhney et al. Feb 2004 B2
6692512 Jang Feb 2004 B2
6726651 Robinson et al. Apr 2004 B1
6726702 Khosravi Apr 2004 B2
6749619 Ouriel et al. Jun 2004 B2
6755813 Ouriel et al. Jun 2004 B2
6780193 Leslie et al. Aug 2004 B2
6805692 Muni et al. Oct 2004 B2
6869431 Maguire et al. Mar 2005 B2
6885115 Hatori et al. Apr 2005 B2
6887257 Salahieh et al. May 2005 B2
6913600 Valley et al. Jul 2005 B2
6986778 Zadno-Azizi Jan 2006 B2
7011672 Barbut et al. Mar 2006 B2
7060082 Goll et al. Jun 2006 B2
7108708 Cheng et al. Sep 2006 B2
7125414 Blackledge et al. Oct 2006 B2
7144408 Keegan et al. Dec 2006 B2
7150737 Purdy et al. Dec 2006 B2
7153320 Euteneuer et al. Dec 2006 B2
7163520 Bernard et al. Jan 2007 B2
7166570 Hunter et al. Jan 2007 B2
7220270 Sawhney et al. May 2007 B2
7261727 Thielen Aug 2007 B2
7544202 Cartier et al. Jun 2009 B2
7985236 Pepper Jul 2011 B2
8231519 Reichenbach et al. Jul 2012 B2
20010001812 Valley et al. May 2001 A1
20010031981 Evan et al. Oct 2001 A1
20020062134 Barbut et al. May 2002 A1
20020072730 McGill et al. Jun 2002 A1
20020082525 Oslund et al. Jun 2002 A1
20020082636 Sawhney et al. Jun 2002 A1
20020091407 Zadno-Azizi et al. Jul 2002 A1
20020107479 Bates et al. Aug 2002 A1
20020107506 McGuckin, Jr. et al. Aug 2002 A1
20020115983 Sekino et al. Aug 2002 A1
20020165575 Saleh Nov 2002 A1
20020188313 Johnson et al. Dec 2002 A1
20030009146 Muni et al. Jan 2003 A1
20030032941 Boyle et al. Feb 2003 A1
20030050600 Reesemann et al. Mar 2003 A1
20030093110 Vale May 2003 A1
20030097082 Purdy et al. May 2003 A1
20030097094 Ouriel et al. May 2003 A1
20030125764 Brady et al. Jul 2003 A1
20030144686 Martinez et al. Jul 2003 A1
20030176889 Boyle et al. Sep 2003 A1
20030187495 Cully et al. Oct 2003 A1
20030203031 Shah Oct 2003 A1
20030208222 Zadno-Azizi Nov 2003 A1
20030212429 Keegan et al. Nov 2003 A1
20030212434 Thielen Nov 2003 A1
20030233117 Adams et al. Dec 2003 A1
20040006367 Johnson et al. Jan 2004 A1
20040011740 Bernard et al. Jan 2004 A1
20040044302 Bernard et al. Mar 2004 A1
20040102806 Broome et al. May 2004 A1
20040125764 Brady et al. Jul 2004 A1
20040153112 Nissenbaum et al. Aug 2004 A1
20040158276 Barbut et al. Aug 2004 A1
20040162576 Barbut et al. Aug 2004 A1
20040199177 Kim Oct 2004 A1
20040220612 Swainston et al. Nov 2004 A1
20040236170 Kim Nov 2004 A1
20040254528 Adams et al. Dec 2004 A1
20050021075 Bonnette et al. Jan 2005 A1
20050027236 Douk et al. Feb 2005 A1
20050038468 Panetta et al. Feb 2005 A1
20050038503 Greenhalgh et al. Feb 2005 A1
20050080445 Sawhney et al. Apr 2005 A1
20050085769 MacMahon et al. Apr 2005 A1
20050085841 Eversull et al. Apr 2005 A1
20050107817 White et al. May 2005 A1
20050113862 Besselink et al. May 2005 A1
20050133046 Becker et al. Jun 2005 A1
20050142163 Hunter et al. Jun 2005 A1
20050145258 Dong Jul 2005 A1
20050147562 Hunter et al. Jul 2005 A1
20050147599 Hunter et al. Jul 2005 A1
20050147643 Hunter et al. Jul 2005 A1
20050148512 Hunter et al. Jul 2005 A1
20050148997 Valley et al. Jul 2005 A1
20050158274 Hunter et al. Jul 2005 A1
20050169958 Hunter et al. Aug 2005 A1
20050169959 Hunter Aug 2005 A1
20050175657 Hunter et al. Aug 2005 A1
20050177186 Cully et al. Aug 2005 A1
20050186247 Hunter et al. Aug 2005 A1
20050191248 Hunter et al. Sep 2005 A1
20050192620 Cully et al. Sep 2005 A1
20050197624 Goodson et al. Sep 2005 A1
20050205097 Kyle, Jr. Sep 2005 A1
20050245962 Adams et al. Nov 2005 A1
20050261733 Cheng et al. Nov 2005 A1
20050267408 Grandt et al. Dec 2005 A1
20050267442 Von Oepen Dec 2005 A1
20050277976 Galdonik et al. Dec 2005 A1
20050283182 Pierce et al. Dec 2005 A1
20050288704 Cartier et al. Dec 2005 A1
20060025840 Willard Feb 2006 A1
20060135961 Rosenman et al. Jun 2006 A1
20060189921 Galdonik et al. Aug 2006 A1
20060190025 Lehe et al. Aug 2006 A1
20060200191 Zadno-Azizi Sep 2006 A1
20060229657 Wasicek et al. Oct 2006 A1
20060240063 Hunter et al. Oct 2006 A9
20060240064 Hunter et al. Oct 2006 A9
20060241675 Johnson et al. Oct 2006 A1
20060241676 Johnson et al. Oct 2006 A1
20060241677 Johnson et al. Oct 2006 A1
20060241678 Johnson et al. Oct 2006 A1
20060241679 Johnson et al. Oct 2006 A1
20060241680 Johnson et al. Oct 2006 A1
20060248871 Johnson et al. Nov 2006 A1
20060271098 Peacock, III Nov 2006 A1
20070006441 McNiven et al. Jan 2007 A1
20070016132 Oepen et al. Jan 2007 A1
20070016165 Von Oepen et al. Jan 2007 A1
20070021771 Oepen et al. Jan 2007 A1
20070055365 Greenberg et al. Mar 2007 A1
20070060942 Zadno-Azizi Mar 2007 A2
20070065484 Chudzik et al. Mar 2007 A1
20070083188 Grandt et al. Apr 2007 A1
20070123838 Bernard et al. May 2007 A1
20070129752 Webler et al. Jun 2007 A1
20070129753 Quinn et al. Jun 2007 A1
20070135832 Wholey et al. Jun 2007 A1
20070191717 Rosen et al. Aug 2007 A1
20070020455 Knott et al. Sep 2007 A1
20070208374 Boyle et al. Sep 2007 A1
20070244503 Casey et al. Oct 2007 A1
20070293930 Wang et al. Dec 2007 A1
20080051671 Broome et al. Feb 2008 A1
20090043332 Sullivan et al. Feb 2009 A1
20090062480 Angel Mar 2009 A1
20100137892 Krolik et al. Jun 2010 A1
20110190727 Edmunds et al. Aug 2011 A1
20120130395 Vardi May 2012 A1
20120158039 Angel et al. Jun 2012 A1
20130289716 Don Michael Oct 2013 A1
20160089172 Windheuser Mar 2016 A1
Foreign Referenced Citations (40)
Number Date Country
WO 1996030073 Oct 1996 WO
WO 1997017100 May 1997 WO
WO 1997042879 Nov 1997 WO
WO 1998046297 Oct 1998 WO
WO 1999065420 Dec 1999 WO
WO 2000009190 Feb 2000 WO
WO 2001013983 Mar 2001 WO
WO 2001037921 May 2001 WO
WO 2001052768 Jul 2001 WO
WO 2001065936 Sep 2001 WO
WO 2002030271 Apr 2002 WO
WO 2002039878 May 2002 WO
WO 2002040090 May 2002 WO
WO 2002064202 Aug 2002 WO
WO 2003015859 Feb 2003 WO
WO 2003084437 Oct 2003 WO
WO 2004014240 Feb 2004 WO
WO 2004049932 Jun 2004 WO
WO 2004054650 Jul 2004 WO
WO 2004060465 Jul 2004 WO
WO 2004098674 Nov 2004 WO
WO 2005011786 Feb 2005 WO
WO 2005023358 Mar 2005 WO
WO 2005046746 May 2005 WO
WO 2005058384 Jun 2005 WO
WO 2005065079 Jul 2005 WO
WO 2005074520 Aug 2005 WO
WO 2005091910 Oct 2005 WO
WO 2005118044 Dec 2005 WO
WO 2005118045 Dec 2005 WO
WO 2005118050 Dec 2005 WO
WO 2006065949 Jun 2006 WO
WO 2006074163 Jul 2006 WO
WO 2006089178 Aug 2006 WO
WO 2006104591 Oct 2006 WO
WO 2006105065 Oct 2006 WO
WO 2006116636 Nov 2006 WO
WO 2006127929 Nov 2006 WO
WO 2007035865 Mar 2007 WO
WO 2007035885 Mar 2007 WO
Non-Patent Literature Citations (26)
Entry
Decousus, et al., “A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis” N Engl J Med 338(7):409-415 (1998).
Extended Search Report from corresponding application, EP 08799012.3, pp. 1-7 (dated Jun. 6, 2011).
Extended Search Report from corresponding application, EP 11732246.1, pp. 1-9 (dated Jun. 2, 2016).
Greenfield, L., et al., “A new intracaval filter permitting continued flow and resolution of emboli” Surgery 73(4): 599-606 (1973).
Lin, et al., “Vena caval filters in the treatment of acute DVT” Endovascular Today Jan: 40-50 (2005).
Mobin-Uddin, et al., “experimental prevention of myocardial infarction by bronchial collateral circulation” JAMA 208(2): 301-306 (1969).
International Preliminary Report on Patentability from corresponding PCT international application PCT/US2014/017170, pp. 1-14 (dated Sep. 17, 2015).
PCT International Search Report from corresponding PCT international application PCT/US2008/074885, pp. 1-3 (dated Nov. 26, 2008).
PCT International Search Report from corresponding PCT international application PCT/US2011/020599, pp. 1-7 (dated Oct. 31, 2011).
PCT Written Opinion from corresponding PCT international application PCT/US2008/074885, pp. 1-8 (dated Nov. 26, 2008).
PCT Written Opinion from corresponding PCT international application PCT/US2011/020599, pp. 1-5 (dated Oct. 31, 2011).
PCT International Preliminary Report on Patentability from corresponding PCT international application PCT/US2008/074885; pp. 1-9 (dated Mar. 2, 2010).
PCT International Preliminary Report on Patentability from corresponding PCT international application PCT/US2011/020599, pp. 1-7 (dated Jul. 19, 2012).
Patent Examination Report No. 1 from corresponding foreign application AU 2008292832, pp. 1-7 (dated Jan. 4, 2013).
Patent Examination Report No. 2 from corresponding foreign application AU 2008292832, pp. 1-6 (dated Jun. 23, 2014).
Office Action from corresponding foreign application CA 2698109, pp. 1-3 (dated Jul. 30, 2014).
Office Action from corresponding foreign application IL 204138, pp. 1-4 (dated Nov. 8, 2011).
EP Extended Search Report and Search Opinion from corresponding foreign application EP 08799012.3; pp. 1-7 (dated Jun. 6, 2011).
EP Patent Examination Report—Communication pursuant to Article 94(3) from corresponding foreign application EP 08799012.3; pp. 1-4 (dated Sep. 9, 2013).
EP Patent Examination Report—Communication pursuant to Article 94(3) from corresponding foreign application EP 08799012.3; pp. 1-3 (dated Jan. 27, 2016).
EP Patent Examination Report—Communication pursuant to Article 94(3) from corresponding foreign application EP 08799012.3; pp. 1-4 (dated Aug. 25, 2018).
Patent Examination Report No. 1 from corresponding foreign application AU 2011203980, pp. 1-3 (dated Feb. 17, 2014).
EP Extended Search Report and Search Opinion from corresponding foreign application EP 11732246.1; pp. 1-9 (dated Jun. 2, 2016).
Office Action from corresponding foreign application CA 2783378, pp. 1-4 (dated Oct. 27, 2016).
Office Action from corresponding foreign application IL 220745, pp. 1-3 (dated Mar. 4, 2015).
Office Action from corresponding foreign application IL 220745, pp. 1-2 (dated May 1, 2016).
Related Publications (1)
Number Date Country
20190381303 A1 Dec 2019 US
Provisional Applications (1)
Number Date Country
62151812 Apr 2015 US
Divisions (1)
Number Date Country
Parent 15136636 Apr 2016 US
Child 16526016 US